Connect with us

Covid

Covid-19: New AP Strain Might be 15 Times More Virulent

Published

on

Covid-19: New AP Strain Might be 15 Times More Virulent

Undeniably, the second wave of Coronavirus is sending shivers down the spine. And now shockingly, a strain has been found in Andhra Pradesh which is 15 times more virulent. As per experts, the Centre for Cellular and Molecular Biology (CCMB) has discovered N440K variant, that might be responsible for creating havoc in Visakhapatnam and other parts of the State.

And according to reports, the new strain first discovered in Kurnool, is considered to be at least 15 times more virulent than the earlier ones, and may be even stronger than the Indian variants of B1.617 and B1.618.

“We are still to ascertain, which strain is in circulation right now, as samples have been sent to CCMB for analysis. But one thing is certain that the variant at present which is in circulation in Visakhapatnam is quite different from what we have seen during the first wave last year,” District Collector V Vinay Chand, who is updated about the developments by senior doctors in the health department said.

District COVID Special Officer PV Sudhakar said that the new variant has shorter incubation period and the progress of the disease is much rapid. In the earlier cases, a patient affected with Covid-19 would take at least a week to reach the hypoxia or dyspnea stage, but now patients are reaching the serious condition stage within three or four days. He further added that it has led to pressure on beds with oxygen and ICU beds.

Covid

Covid-19 in India: 18,987 new cases in last 24 hours, 20% higher than day before

Published

on

By

Covid-19 in India: 18,987 new cases in last 24 hours, 20% higher than day before

The Union Ministry of Health and Family Welfare (MoHFW) said on Wednesday said that India registered 18,987 new Covid-19 cases in the last 24 hours, which was 20 per cent higher than what the country had witnessed a day before.

Also, total of 246 deaths were reported during the same time, increasing the total reported death count to 4,51,435.

With this, the total Covid caseload in India has increased to 3,40,20,730.

The top five states which have registered maximum cases are Kerala with 11,079 cases, followed by Maharashtra with 2,219 cases, Tamil Nadu with 1,280 cases, Mizoram with 1,028 cases and West Bengal with 771 cases.

Continue Reading

Covid

Covaxin gets emergency use approval for kids aged 2-18 years

Published

on

By

Covaxin gets emergency use approval for kids aged 2-18 years

The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech’s Covaxin for children in the 2-18 years age group.

In September, Hyderabad-based Bharat Biotech had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of age and also submitted the trial data to the Drugs and Comptroller General of India (DCGI).

“After detailed deliberation, the committee recommended for grant of market authorization of the vaccine for the age group of 2 to 18 years for restricted use in emergency situation,” the subject expert panel said in a statement.

 

Continue Reading

Covid

Govt has no data of Covid-19 vaccines given daily by private hospitals

Published

on

By

Govt has no data of Covid-19 vaccines given daily by private hospitals

The Union health ministry has said that it does not hold data of daily Covid-19 vaccines doses administered by private hospitals and health service providers.

In a response to RTI petition and appeal filed by activist Commodore (Retd) Lokesh Batra, the government has said the same

In its first reply, the government mentioned, “Private hospitals/institutions etc procure vaccines directly from the vaccine manufacturers. Data asked pertains between manufacturers and private hospitals/institutions etc. Separate vaccination data is not available, however, the vaccination data ll date can be checked on the below link hps://dashboard.cowin.gov.in/ (sic).”

“This information is not maintained and is not available since procurement of vaccines by private hospitals private healthcare service providers and private entities are done directly from the manufacturers,” the Union health ministry said.

Continue Reading

Trending